Early Treatment of Language Impairment in Young Children with Autism Spectrum Disorder with Leucovorin Calcium

Abstract

Autism Spectrum Disorder (ASD) has an enormous impact on individuals, families and society, yet there is no FDA approved treatment that addresses underlying ASD pathophysiology and/or core deficits. However, a growing body of evidence indicates that leucovorin, a form of folate (vit B9) that bypasses physiological blocks in folate metabolism found in ASD, can significantly improve verbal communication as well as other symptoms associated with ASD.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2023
Accession Number
AD1214651

Entities

People

  • Richard E Frye

Organizations

  • Phoenix Children's Hospital

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Autism
  • Biomedical Research
  • Clinical Trials
  • Data Analysis
  • Diseases
  • Electronic Mail
  • Employment
  • Governments
  • Health Services
  • Hospitals
  • Humanities
  • Institutional Review Board
  • Laboratory Procedures
  • Language
  • Medical Personnel
  • Metabolism
  • Neurodevelopmental Disorders
  • Patent Applications
  • Personalized Medicine
  • Professional Development
  • Social Communication
  • Spectra
  • Students

Fields of Study

  • Medicine

Readers

  • Marine Ecological Systems Migration
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Molecular and Cellular Biochemistry